We will be exploring, developing a better understanding, and uncovering strategies & tactics to enhance Swiss market access (reimbursement) for digital health technologies (DHTs), including MedTech and Medical Devices.
 
With our combined expertise in digital health technologies, we’ll invite key stakeholders to share their insights, where we will:
 
a. discuss their challenges, opportunities, and successes in the Swiss market access ecosystem.
b. delve into their pain points, constraints, and innovative solutions shaping the future. 

What you'll gain from listening to our podcast on Swiss Market Access:

1. Valuable insights into Swiss regulations and guidance on digital health technologies.
2. A deeper understanding of decision-making and strategic planning in Switzerland. 
3. Greater confidence navigating the Swiss digital health industry—an emerging market.

Our listeners like you, who are digital health leaders & innovators. Especially Swiss-based or focused:

• Industry:  payers & insurance companies, commercial manufacturers, tech providers, and medtech associations.
• Health Startups: including software developers & engineers.
• National component agencies including regulatory and/or those conducting value assessments on digital health technologies.
• Clinical: clinicians, healthcare professionals, and hospital administrators.
• Patients & Advocates: patients, organizations, and patient leaders. Ethicists.
• Academic & Research: researchers, academics, & digital biomarkers researchers.
• Innovation Centres:  digital health hubs and Innovation and education-focused groups.
• And those interested in launching their digital health technologies in Switzerland.

If you are one or more of the above stakeholders but are too busy to read & process updates on market access (reimbursement) considerations on digital health technologies in Switzerland, then you are our listener. Subscribe & give our podcast a listen! 

Upcoming Monthly Episodes:

• Gurmit discusses with Angelina his research journey on the dashboard on the value assessment of digital health technologies. When presenting at HTAi conference, it validated the relevance of his research.
• Angelina discusses with Gurmit her experiences as a lawyer working in life sciences, particularly on Swiss market acce

GET IN TOUCH:

Feedback? We’re listening. Send us a message on LinkedIn:
https://linkedin.com/in/gurmitsandhu | https://linkedin.com/in/angelina-rau

Share your experience, feedback, “pain points” or success with market access & reimbursement of digital health technology #medtech #meddevice :
on the comments section below or DM us on LinkedIn

Do you know someone who would be a great guest for us to interview? Let us know via LinkedIn | Topics that you want us to focus on. Drop us a comment below!

What to Read:

Reimbursement guide on digital health applications within the Swiss healthcare system | Created in collaboration with experts in insurance, law, pharma, and industry including Angelina Rau | Free access, in Eng & De =>
https://swisshealthcarestartups.com/en/reimbursement-guide

Kohler, Stefan / Rau, Angelina, Vergütung digitaler Gesundheitsanwendungen in der Schweiz, Life Sciences Recht Stämpfli, LSR 1/2023, S. 13-22, Januar 2023

Sandhu G, Mohamed Ghazali IM, Laurenzi E, Miho E. PP22 A Dashboard To Support The Value Assessment Of Digital Health Technologies For H...